Linezolid
Cross-source consensus on Linezolid from 1 sources and 4 claims.
1 sources · 4 claims
Uses
How it works
Dosage & preparation
Highlighted claims
- Participants assigned to linezolid receive 600 mg orally twice daily for 5 days. — Linezolid in addition to standard antibiotic treatment for Staphylococcus aureus bacteraemia: study protocol for a randomised, placebo-controlled trial
- Linezolid is being tested because preclinical studies indicate it suppresses S. aureus virulence factors linked to persistence and tissue damage. — Linezolid in addition to standard antibiotic treatment for Staphylococcus aureus bacteraemia: study protocol for a randomised, placebo-controlled trial
- The LIPS trial tests whether early adjunctive linezolid can improve outcomes beyond bacterial clearance alone. — Linezolid in addition to standard antibiotic treatment for Staphylococcus aureus bacteraemia: study protocol for a randomised, placebo-controlled trial
- No linezolid dose modifications are allowed, including for renal impairment. — Linezolid in addition to standard antibiotic treatment for Staphylococcus aureus bacteraemia: study protocol for a randomised, placebo-controlled trial